Skip to content
Cage Pharma logo — Innovative pre-clinical biopharma advancing tumor-targeting...

Cage Pharma

Innovative pre-clinical biopharma advancing tumor-targeting therapies with groundbreaking encapsulated formulations for more effective cancer treatment.

Founded 2017 0-1 employees Venture round Total: $967.49K Biopharma, Biotechnology +1

General Information

Company Name Cage Pharma
Founded Year 2017
Employees 0-1
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Cage Pharma. To contact Cage Pharma, visit cagephar.ma.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cage Pharma compare?

A PDF of Cage Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cage Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cage Pharma

Cage Pharma is an innovative pre-clinical biopharmaceutical startup, focusing on the development of tumor-targeting therapies with groundbreaking encapsulated formulations for more effective cancer treatment. The company's encapsulated anti-cancer agent utilizes a novel formulation of 3-bromopyruvate to target cancer by attacking tumor glycolysis, a critical feature of cancer cells. This approach allows for the effective use of the anti-cancer agent while maintaining a controlled and mild toxicity profile. Founded in 2017, Cage Pharma is headquartered in Baltimore, Maryland. The company recently secured a $137.49K Venture Round investment on 31 May 2024. Cage Pharma operates in the Biopharma, Biotechnology, and Pharmaceutical industries, positioning itself at the forefront of cutting-edge cancer treatment development.

Business keywords: pre-clinical biopharma, tumor-targeting therapy, cancer treatment, encapsulated formulations, 3-bromopyruvate, tumor metabolism, anti-cancer agent, novel formulation, controlled toxicity profile, Baltimore, Maryland, drug development, biopharmaceutical company

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $137.49K -
31 May 2024
Seed Round $480.00K -
10 Jul 2019
Seed Round $350.00K -
05 Jan 2018

Cage Pharma Alternatives & Competitors

View All Alternatives
Cage Pharma vs

Pioneering advancements in the fight against high-impact cancers and neurodegenerative diseases with...

Venture round
12 employees
Biotechnology, Pharmaceutical
Cage Pharma vs

Rare Science. Rare Compassion. Rare Solutions.

11 employees
Biotechnology, Pharmaceutical
Cage Pharma vs

Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...

Series B
11 employees
Biotechnology, Health and Wellness

FAQ About Cage Pharma

Innovative pre-clinical biopharma advancing tumor-targeting therapies with groundbreaking encapsulated formulations for more effective cancer treatment.
Cage Pharma was founded in 2017.
Cage Pharma operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on pre-clinical biopharma, tumor-targeting therapy, cancer treatment and encapsulated formulations.
Cage Pharma has approximately 0-1 employees.
Cage Pharma has completed 3 funding rounds, raising a total of $967.49K. The latest funding stage is Venture round.
Top alternatives and competitors to Cage Pharma include Actuate Therapeutics, Inc., Cornerstone Pharmaceuticals, Cybrexa Therapeutics, MACROPHAGE PHARMA LIMITED, Heidelberg Pharma Research GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cage Pharma and Actuate Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cage Pharma, https://bouncewatch.com/company/cage-pharma, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout